Influenza, a communicable disease, affects thousands of people worldwide. Young children, 3 elderly, immunocompromised individuals and pregnant women are at higher risk for being 4 infected by the influenza virus. Our study aims to highlight differentially expressed genes in 5 influenza disease compared to influenza vaccination. We also investigate genetic variation 6 due to the age and sex of samples. To accomplish our goals, we conducted a meta-analysis 7 using publicly available microarray expression data. Our inclusion criteria included subjects with 8 influenza, subjects who received the influenza vaccine and healthy controls. We curated 18 9 microarray datasets for a total of 3,481 samples (1,277 controls, 297 influenza infection, 1,907 10 influenza vaccination). We pre-processed the raw microarray expression data in R using packages 11 available to pre-process Affymetrix and Illumina microarray platforms. We used a Box-Cox power 12 transformation of the data prior to our down-stream analysis to identify differentially expressed 13 genes. Statistical analyses were based on linear mixed effects model with all study factors and 14 successive likelihood ratio tests (LRT) to identify differentially-expressed genes. We filtered LRT 15 results by disease (Bonferroni adjusted p-value < 0.05) and used a two-tailed 10% quantile cutoff 16 to identify biologically significant genes. Furthermore, we assessed age and sex effects on the 17 disease genes by filtering for genes with a statistically significant (Bonferroni adjusted p-value < 18 0.05) interaction between disease and age, and disease and sex. We identified 4,889 statistically 19 significant genes when we filtered the LRT results by disease factor, and gene enrichment analysis 20 (gene ontology and pathways) included innate immune response, viral process, defense response 21 to virus, Hematopoietic cell lineage and NF-kappa B signaling pathway. Our quantile filtered gene 22 lists comprised of 978 genes each associated with influenza infection and vaccination. We also 23 identified 907 and 48 genes with statistically significant (Bonferroni adjusted p-value < 0.05) 24 disease-age and disease-sex interactions respectively. Our meta-analysis approach highlights 25 key gene signatures and their associated pathways for both influenza infection and vaccination. 26 1 Rogers LRK et al.
as null hypothesis and the interaction models as alternative hypotheses. P-values were adjusted using Bonferroni, where for the first test (i) the number of tests was equal to the number of genes, and for the 153 second one (ii) the number of tests was equal to the number of genes that passed the first test. 154 The filtering of genes based on Bonferroni-adjusted p-values for the main effect of disease (comparison 155 of M1 to M0) allowed us to identify differentially expressed genes with respect to disease states (Figure 1) . 156 Using this gene list, we then conducted GO enrichment analysis (GOAnalysis function in MathIOmica 157 package) and pathway enrichment analysis using Kyoto Encyclopedia of Genes and Genomes (KEGG, 158 using the KEGGAnalysis functions in MathIOmica), and Reactome pathway enrichment analysis 159 (enrichPathway function from the ReactomePA package in R (30)). 
Determining Gene Expression Variability between Influenza Infection and 161
Vaccination 162 We took a sequential testing approach to further analyze the identified statistically significant disease 163 genes (SDF5 of online supplementary data files). Using this gene list, we further filtered for biological effect 164 by using calculated estimates (which compared influenza and vaccine expression to controls) (SDF4 of 165 online supplementary data files) and performed a two-tailed 10% quantile filter (i.e. 0.1 and 0.9 quantiles) 166 to determine genes that were biologically significant in subjects who were vaccinated with influenza 167 vaccinated and subjects infected with influenza disease. The biologically significant gene lists for the 168 vaccinated and influenza subjects were further examined to identify genes in common, and genes only in 169 the influenza list, and only in the vaccinated list ( Figure 1 ). We performed GO and pathway enrichment 170 analysis on these genes. Lastly, we filtered the disease (see SDF1 of online supplementary data files) 171 statistically significant gene list for interacting genes between disease and age (age groups: (-1,3], (3, 19] , 172 (19,65], (65,100])) and disease and sex.
173

RESULTS
Our data curation criteria resulted in 3,481 samples (1,277 controls, 297 influenza infection, 1,907 influenza 174 vaccinated, 1,537 males and 1,944 females) (see SDF1 of online supplementary data files). Our 3,481 175 samples are from 1,147 individuals. Some studies include repeated measures (in the curated studies 176 individuals were followed for several days after vaccination or infection and varying timepoints were 177 reported as a different samples for the same subject). We included all repeated measures in our downstream 178 analysis and accounted for them in our model. The main results are summarized below, and further 179 discussed in the Discussion Section 4. 
Differentially Expressed Genes in Influenza Disease and Vaccination
181
Filtering our LRT analysis results by disease factor (see SDF3 of online supplementary data files) for 182 Bonferroni adjusted p-values (< 0.05), we identified 4,889 statistically significant disease genes (see SDF5 183 of online supplementary data files). We performed GO enrichment analysis using BINGO in Cytoscape 184 (version 3.7) (31, 32) and pathway enrichment analysis on the 4,889 genes ( Supplementary Figures 1-5 185 and see SDF6-SDF8 of online supplementary data files). We identified enriched GO terms such as: cell 186 cycle checkpoint (51 genes), response to stimulus (987 genes), immune response (243 genes), transcription 187 (122 genes), regulation of T-cell activation (62 genes), regulation of defense response to virus by host 188 (8 genes) and immune system process (379 genes) (see SDF8 of online supplementary data files for full signaling pathway (46 genes), Metabolic pathways (341 genes), Primary immunodeficiency (23 genes), T cell receptor signaling pathway (44 genes), B cell receptor signaling pathway (29 genes) and also 193 Influenza A (52 genes). We also highlighted the NF-kappa B signaling pathway and the Influenza A KEGG 194 pathways that are relevant to disease with our calculated estimates which compared influenza infection and 195 vaccination expression to that of healthy controls (Figures 4 -7) . 196 In addition, we filtered the 4,889 genes for effect size to determine biological significance of the genes 197 (SDF4 of online supplementary data files). We used a two-tailed 10% and 90% quantile filter on the 198 4,889 genes to: (i)analyze the influenza disease estimates (compared expression to control) list to identify 199 genes that are biologically significant and statistically significant (Bonferroni-adjusted p-value <0.05) 200 in influenza infection (ii) analyze the influenza vaccination estimates with the same filtering approach 201 to also identify significant genes for influenza vaccination. For influenza infection our 10% and 90% 202 quantile cut-offs for biological significance were ≤-0.6724464 and ≥ 0.5949655 respectively. For influenza 203 vaccination, the 10% and 90% quantile cut-offs were ≤ -0.07157763 and ≥0.06719048 respectively. For 204 influenza infection we identified 978 genes of the 4,889 to be biologically significant ( Table 3 and SDF9 205 of online supplementary data files), and we also identified 978 genes to be biologically significant for 206 influenza vaccination (Table 3 and SDF10 of online supplementary data files). We then compared the two 207 gene lists to identify the intersection (genes in common), genes only in the influenza disease list, and 208 genes only in the influenza vaccination list ( Figure 1D and SDF11-SDF13 of online supplementary data 209 files). There were 334 genes in common across both lists (influenza disease and vaccination) (SDF17 of 210 online supplementary data files) that resulted in enriched Reactome pathways such as Interferon alpha/beta 211 signaling (14 genes), Interferon gamma signaling (12 genes), Antiviral mechanism by IFN-stimulated 212 genes (9 genes), and Cell Cycle Checkpoints (17 genes) (SDF20 of online supplementary data files).
213
There were 644 genes that were only in influenza infection list (SDF18 of online supplementary data files) genes) (SDF21 of online supplementary data files). Also, we identified another 644 genes that were only 218 in the biologically significant list for the vaccinated subjects (SDF19 of online supplementary data files).
219
Enriched Reactome pathway analysis on these genes resulted in pathways such as Interferon Signaling (24 220 genes), Antigen processing-Cross presentation (14 genes), ER-Phagosome pathway (12 genes), Binding 221 and Uptake of Ligands by Scavenger Receptors (8 genes) and Class I MHC mediated antigen processing & 222 presentation (30 gene) (SDF22 of online supplementary data files). 223 We also explored the 4,889 genes to identify how many genes were different in gene expression when 224 looking at influenza infected subjects compared to influenza vaccinated subjects. Of the 4,889 genes, 4,261 225 genes showed statistically significant differences between vaccination and infection with influenza ( Figure   226 3 and SDF25 -SDF27 of online supplementary data files). 
Age and Sex Effect on Gene Expression in Influenza 228
Using the 4,889 genes disease significant genes from above, we Bonferroni-adjusted the p-values for both 229 the age and sex factors. We then further filtered the 4,889 list by the age factor p-values (Bonferroni-adjusted 230 p-value < 0.05) to identify statistically significant interacting genes between disease state and age (DxA). 231 We also repeated this approach for the sex factor interaction with disease (DxS). Of the 4,889 statistically 232 significant (Bonferroni-adjusted p-value <0.05) disease genes, 907 of them had a statistically significant 233 interaction with disease and age (SDF28 of online supplementary data files). KEGG enrichment, our results include: Cytokine-cytokine receptor interaction (34 genes), T cell receptor signaling pathway (19 genes), our findings (978 genes, see SDF9 of online supplementary data files). 5 of our top 10 up-regulated gene 320 list overlap with the Dunning et al. 25-gene set (Table 3) , namely UGCG, CD177, OTOF, HP and SSH1.
321
Furthermore, our identified biologically significant gene lists for influenza infection and vaccination 322 (using a 2-tailed 10% quantile filter on expression estimates of effect size compared to healthy control) 323 have 334 genes in common, with 644 genes being unique to influenza infection and 644 being unique to 324 influenza vaccination (SDF17-SDF19 of online supplementary data files). Following pathway enrichment, 325 we observed that the genes that are unique to each disease state (influenza infected and vaccinated) are 326 involved in different processes. For example, the biologically significant genes only in influenza infected 327 samples were enriched in pathways such as neutrophil degranulation and cell cycle checkpoints (SDF21 of 328 online supplementary data files). Neutrophil degranulation is a defensive process neutrophils undergo to 329 protect the host against invading pathogens. On the other hand, pathways involved in interferon signaling 330 and antigen processing were enriched for the genes only in the vaccinated gene list (SDF22 of online 331 supplementary data files). This indicates that with the actual infection the body undergoes different 332 processes to that induced by vaccination ( Supplementary Figures 3-4 and see SDF23 and SDF24 of online 333 supplementary data files).
334
The 48 genes for which we identified a statistically significant interaction between disease and sex 335 are highlighted in SDF29 of the online supplementary data files. Sex-specific gene expression has been 336 previously observed in influenza. Studies have observed females exhibited a stronger immune response to 337 influenza vaccine compared to males within the first day (47). Another study suggested that males have a 338 stronger immune response to influenza infection (48). These findings indicate sex and influenza is still to 339 be explored and our gene list may offer new candidates to be investigated for their role in influenza.
340
With regards to aging and influenza, the statistics of the disease burden indicates specific age groups 341 are at higher risk for infection (3). This is in part due to immune system development and deterioration.
342
For example, B and T cell function diminishes with age (49, 33). In our analysis, we identified 907 343 disease-associated genes with a statistically significant interaction with age that were also enriched in 344 immune related KEGG pathways (SDF30 of online supplementary data files). Figure 8 In Figure 9 we further explored changes in gene expression across age groups due to influenza infection 354 of our 907 disease:age interacting genes. Figure 9A is compares influenza infected subjects in age groups 355 2,3 and 4 to the baseline (infection subjects under 3). In Figure 9A there Figure 11 . Heatmap of Statistically Significant (Bonferroni-adjusted p-value <0.05) Genes with an Interaction Between Disease State and Age for Influenza Vaccinated Subjects Compared to Influenza Infected Subjects. Comparison of baseline-adjusted means for influenza vaccinated subjects ( Figure 10A ) and influenza infected subjects ( Figure 9A ).
